|
Volumn 11, Issue 23, 2012, Pages 4296-4297
|
Forever young? Exploring the link between rapamycin, longevity and cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
INITIATION FACTOR 4E;
MAMMALIAN TARGET OF RAPAMYCIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE B;
PROTEIN P53;
RAPAMYCIN;
RAPAMYCIN DERIVATIVE;
RAPATAR;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
TARGET OF RAPAMYCIN KINASE;
AGING;
ANTINEOPLASTIC ACTIVITY;
CANCER MORTALITY;
CANCER PREVENTION;
CARCINOGENESIS;
DRUG EFFICACY;
DRUG MECHANISM;
EDITORIAL;
LONGEVITY;
NONHUMAN;
SIGNAL TRANSDUCTION;
SURVIVAL;
ANIMAL;
DISEASE COURSE;
DRUG ANTAGONISM;
GENETICS;
METABOLISM;
MOUSE;
MOUSE MUTANT;
NEOPLASM;
PATHOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DISEASE PROGRESSION;
LONGEVITY;
MICE;
MICE, KNOCKOUT;
NEOPLASMS;
SIGNAL TRANSDUCTION;
SIROLIMUS;
TOR SERINE-THREONINE KINASES;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 84870938511
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.22868 Document Type: Editorial |
Times cited : (5)
|
References (9)
|